Concepedia

Shengyan Xiang

SX

Statistics

Publications

17

Citations

1.3K

H-Index

17

Active since

2006

Affiliations

University of South Florida(Current)

Moffitt Cancer Center

The Barbara Ann Karmanos Cancer Institute

Wayne State University

Peking University

Shengyan Xiang is an author at University of South Florida specializing in oncology, molecular biology, and molecular oncology.

ORCID

Publications per year

2006–2021

17

Publications

17

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

Xiaojia Niu, Jianyun Zhao, Jun Ma et al. · Clinical Cancer Research · 2016 · 248 citations · Full text

, , +16

HDAC6 Deacetylates and Ubiquitinates MSH2 to Maintain Proper Levels of MutSα

Mu Zhang, Shengyan Xiang, Heui-Yun Joo et al. · Molecular Cell · 2014 · 162 citations · Full text

, , +4

GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors

Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang et al. · Nature Communications · 2018 · 126 citations · Full text

, , +16

Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration

Kendra A. Williams, Mu Zhang, Shengyan Xiang et al. · Journal of Biological Chemistry · 2013 · 110 citations · Full text

, , +16

Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells

Lei Wang, Shengyan Xiang, Kendra A. Williams et al. · PLoS ONE · 2012 · 84 citations · Full text

, , +16

1–5 of 17